Ozempic and its cousins — Wegovy, Mounjaro, Zepbound — have been hailed as breakthrough drugs in the global fight against obesity. Originally developed for type 2 diabetes, these medications are now being prescribed more widely for their powerful weight-loss effects. Social media is saturated with astonishing before-and-after photos. Celebrities are admitting, or denying, their use. Clinics have waiting lists. Demand is so high that global shortages are commonplace.
But amid the hype, one crucial reality remains almost entirely absent from the conversation: these drugs don’t just suppress appetite — they suppress the pleasure of eating. And for many people, that trade-off is emotionally profound.
The science behind drugs like Ozempic is relatively straightforward. They mimic a gut hormone called GLP-1, which signals the brain to reduce hunger and increase feelings of fullness. The result? People eat less — often much less — without the constant struggle of willpower. Food loses its grip.
For a society desperate for a pharmacological solution to obesity, this seems like the magic bullet. But there’s a catch. For the drug to work, the user must come to terms with a simple but difficult reality: you will likely no longer enjoy food as you once did.
Some patients report feeling indifferent to food. Others say they forget to eat. Even long-standing favorite meals may become unappetizing. This is not a temporary side effect for many users — it’s the mechanism of action. The drug is working because food no longer stimulates the brain’s reward system in the same way.
And that’s where the problem lies. Because for millions of people — particularly those who are obese — eating isn’t just about satisfying hunger. It’s about comfort, celebration, routine, identity, and emotional regulation. Meals are moments of joy, calm, or control in otherwise chaotic lives. Taking that away, even in the name of health, is not a neutral exchange.
The media rarely mentions this. Headlines focus on pounds lost, health markers improved, and success stories told with glossy enthusiasm. The emotional cost is ignored, as if food pleasure were trivial — a bad habit best forgotten. But for those who have used food as a source of pleasure, especially in a world that offers few other comforts, this shift can be quietly devastating.
Some users report a kind of grief. They miss the joy of meals, the anticipation of a treat, the ritual of eating with friends. A few even describe feeling detached or less alive. Others find that the loss of food pleasure leaves a vacuum that’s hard to fill. And eventually, some stop taking the drug — not because it didn’t work, but because it worked too well.
This is a barrier to long-term adherence that almost no one talks about. Weight loss clinics don’t tend to lead with “You may never enjoy eating again.” Pharmaceutical companies understandably emphasize medical outcomes. Even public health discussions frame these drugs as tools to combat disease, not disrupt daily emotional life. But for a significant proportion of patients, the loss of eating pleasure is a steep price — and it deserves to be part of the informed consent conversation.
This isn’t to say the drugs are bad. They’re a remarkable development in metabolic medicine. For people facing obesity-related health crises, the trade-off may be entirely worthwhile. Some users welcome the break from food obsession. Others experience a liberation from cravings that felt like chains.
But we must start talking honestly about the psychological cost. If eating is one of the few daily pleasures someone has — and for many people, it is — then removing that pleasure can feel like a loss of self. Thinness bought at the expense of joy may not be sustainable, or even desirable, for everyone.
In our rush to embrace medical weight loss, we must not forget the complex role food plays in human life. It’s nourishment, yes, but also memory, culture, comfort, and love. If a drug diminishes those dimensions, it may solve one problem while creating another — a life with fewer pounds, but also fewer pleasures.
Let’s have a more honest conversation — one that respects not just the science of weight loss, but the humanity of those seeking it.
P.S. Despite the news media often describing this as a wonder drug that can also prevent cancer (today in The Times), it is a drug which circumvents the fundamental need of people to demonstrate self-discipline in eating less. We have completely ignored the fundamental issues. People who are obese due to overindulgent eating need to sharpen up and learn self-discipline and eat less.
Governments need to ban ultra-processed food advertising across the board. And start controlling the food manufacturers. We need much stronger government.
This drug is a product of failure in human behaviour and capitalism.
